Return On Equity of Celldex Therapeutics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Celldex Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Celldex Therapeutics, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -42%, a 110% decline year-over-year.
  • Celldex Therapeutics, Inc. annual Return On Equity for 2025 was -42%, a 110% decline from 2024.
  • Celldex Therapeutics, Inc. annual Return On Equity for 2024 was -20%, a 56% increase from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Celldex Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -42% -22% -110% 01 Oct 2025 31 Dec 2025
Q3 2025 -33% 01 Jul 2025 30 Sep 2025
Q2 2025 -28% 01 Apr 2025 30 Jun 2025
Q1 2025 -23% 01 Jan 2025 31 Mar 2025
Q4 2024 -20% 01 Oct 2024 31 Dec 2024

Celldex Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -42% -22% -110% 01 Jan 2025 31 Dec 2025
2024 -20% +25% +56% 01 Jan 2024 31 Dec 2024
2023 -45% 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.